View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Capecitabine 625 / Radiation, Anal Carcinoma
Protocol-ID: 2754 V1.0 (Mini), CAPE625/Radiation, Anal-CaIndication(s)
- Anal Carcinoma; ICD-10 C21.-, C21.0, C21.1, C21.2, C21.8
ST Radiotherapy: Combined radiochemotherapy (SIB-IMRT) |
5 days per week for a total of 5 weeks - Primary tumor and macroscopically affected lymph nodes: 1.8 Gy daily in 32 fractions - Iliacal and inguinal lymph nodes 1.5 Gy/day in 32 fractions Subsequent boost with 2x1.8 Gy to macroscopic residual tumor in week 5. |
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 26.11.2024